590 related articles for article (PubMed ID: 20180736)
1. The INSURE method in preterm infants of less than 30 weeks' gestation.
Dani C; Corsini I; Bertini G; Fontanelli G; Pratesi S; Rubaltelli FF
J Matern Fetal Neonatal Med; 2010 Sep; 23(9):1024-9. PubMed ID: 20180736
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for INSURE failure in preterm infants.
Dani C; Berti E; Barp J
Minerva Pediatr; 2010 Jun; 62(3 Suppl 1):19-20. PubMed ID: 21089712
[TBL] [Abstract][Full Text] [Related]
3. Effect of multiple INSURE procedures in extremely preterm infants.
Dani C; Corsini I; Bertini G; Pratesi S; Barp J; Rubaltelli FF
J Matern Fetal Neonatal Med; 2011 Dec; 24(12):1427-31. PubMed ID: 21506654
[TBL] [Abstract][Full Text] [Related]
4. Minimally invasive surfactant therapy with a gastric tube is as effective as the intubation, surfactant, and extubation technique in preterm babies.
Aguar M; Cernada M; Brugada M; Gimeno A; Gutierrez A; Vento M
Acta Paediatr; 2014 Jun; 103(6):e229-33. PubMed ID: 24628379
[TBL] [Abstract][Full Text] [Related]
5. [Factors related to extubation failure in premature infants less than 32 weeks of gestation].
Deguines C; Bach V; Tourneux P
Arch Pediatr; 2009 Sep; 16(9):1219-24. PubMed ID: 19577908
[TBL] [Abstract][Full Text] [Related]
6. Is it safer to intubate premature infants in the delivery room?
Aly H; Massaro AN; Patel K; El-Mohandes AA
Pediatrics; 2005 Jun; 115(6):1660-5. PubMed ID: 15930230
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for intubation-surfactant-extubation (INSURE) failure and multiple INSURE strategy in preterm infants.
Dani C; Corsini I; Poggi C
Early Hum Dev; 2012 Mar; 88 Suppl 1():S3-4. PubMed ID: 22266202
[TBL] [Abstract][Full Text] [Related]
8. The influence of the technique of surfactant administration (LISA vs INSURE) on the outcomes of respiratory distress syndrome treatment in preterm infants.
Kaniewska U; Gulczyńska E
Dev Period Med; 2019; 23(3):163-171. PubMed ID: 31654994
[TBL] [Abstract][Full Text] [Related]
9. Continuous positive airway pressure failure in preterm infants: incidence, predictors and consequences.
Dargaville PA; Aiyappan A; De Paoli AG; Dalton RG; Kuschel CA; Kamlin CO; Orsini F; Carlin JB; Davis PG
Neonatology; 2013; 104(1):8-14. PubMed ID: 23595061
[TBL] [Abstract][Full Text] [Related]
10. Very early surfactant without mandatory ventilation in premature infants treated with early continuous positive airway pressure: a randomized, controlled trial.
Rojas MA; Lozano JM; Rojas MX; Laughon M; Bose CL; Rondon MA; Charry L; Bastidas JA; Perez LA; Rojas C; Ovalle O; Celis LA; Garcia-Harker J; Jaramillo ML;
Pediatrics; 2009 Jan; 123(1):137-42. PubMed ID: 19117872
[TBL] [Abstract][Full Text] [Related]
11. Predictors of successful extubation of preterm low-birth-weight infants with respiratory distress syndrome.
Szymankiewicz M; Vidyasagar D; Gadzinowski J
Pediatr Crit Care Med; 2005 Jan; 6(1):44-9. PubMed ID: 15636658
[TBL] [Abstract][Full Text] [Related]
12. Nasal CPAP or intubation at birth for very preterm infants.
Morley CJ; Davis PG; Doyle LW; Brion LP; Hascoet JM; Carlin JB;
N Engl J Med; 2008 Feb; 358(7):700-8. PubMed ID: 18272893
[TBL] [Abstract][Full Text] [Related]
13. The outcome of ELBW infants treated with NCPAP and InSurE in a resource-limited institution.
Kirsten GF; Kirsten CL; Henning PA; Smith J; Holgate SL; Bekker A; Kali GT; Harvey J
Pediatrics; 2012 Apr; 129(4):e952-9. PubMed ID: 22430447
[TBL] [Abstract][Full Text] [Related]
14. Predictors for an unsuccessful INtubation-SURfactant-Extubation procedure: a cohort study.
Brix N; Sellmer A; Jensen MS; Pedersen LV; Henriksen TB
BMC Pediatr; 2014 Jun; 14():155. PubMed ID: 24947477
[TBL] [Abstract][Full Text] [Related]
15. Remifentanil for INSURE in preterm infants: a pilot study for evaluation of efficacy and safety aspects.
Welzing L; Kribs A; Huenseler C; Eifinger F; Mehler K; Roth B
Acta Paediatr; 2009 Sep; 98(9):1416-20. PubMed ID: 19485954
[TBL] [Abstract][Full Text] [Related]
16. STRATEGIES OF USING SURFACTANT: RESULTS OF THE FIRST POLISH NATIONAL SURVEY OF DAILY PRACTICE.
Borszewska-Kornacka MK; Kostuch M; Korbal P; Krajewski P;
Dev Period Med; 2015; 19(3 Pt 1):271-6. PubMed ID: 26958689
[TBL] [Abstract][Full Text] [Related]
17. Criteria for Using INSURE in Management of Premature Babies with Respiratory Distress Syndrome.
Awaysheh F; Alhmaiedeen N; Al-Ghananim R; Bsharat A; Al-Hasan M
Med Arch; 2019 Aug; 73(4):240-243. PubMed ID: 31762557
[TBL] [Abstract][Full Text] [Related]
18. Morbidity and mortality of neonatal respiratory failure in China: surfactant treatment in very immature infants.
Wang H; Gao X; Liu C; Yan C; Lin X; Yang C; Lin Z; Zhu W; Yang Z; Yu F; Qiu Y; Liu X; Zhou X; Chen C; Sun B;
Pediatrics; 2012 Mar; 129(3):e731-40. PubMed ID: 22331337
[TBL] [Abstract][Full Text] [Related]
19. The Provo multicenter early high-frequency oscillatory ventilation trial: improved pulmonary and clinical outcome in respiratory distress syndrome.
Gerstmann DR; Minton SD; Stoddard RA; Meredith KS; Monaco F; Bertrand JM; Battisti O; Langhendries JP; Francois A; Clark RH
Pediatrics; 1996 Dec; 98(6 Pt 1):1044-57. PubMed ID: 8951252
[TBL] [Abstract][Full Text] [Related]
20. Five-year single center experience on surfactant treatment in preterm infants with respiratory distress syndrome: LISA vs INSURE.
Buyuktiryaki M; Alarcon-Martinez T; Simsek GK; Canpolat FE; Tayman C; Oguz SS; Kutman HGK
Early Hum Dev; 2019 Aug; 135():32-36. PubMed ID: 31229792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
